Skip to primary content
Skip to secondary content

gutsandgrowth

Pediatric Gastroenterology

gutsandgrowth

Main menu

  • Home
  • About Jay Hochman -Pediatric Gastroenterology Blog

Tag Archives: Orkambi

FDA Expands Use of Cystic Fibrosis Medication

Posted on October 5, 2016 by gutsandgrowth

FDA Expands Use of Orkambi ( lumacaftor/ivacaftor)

screen-shot-2016-09-30-at-7-44-33-am

Related blog post:

  • Lumacaftor-Ivacaftor for Cystic Fibrosis | gutsandgrowth

 

Posted in Pediatrics | Tagged cystic fibrosis, Ivacaftor, lumacaftor, Orkambi

Categories

Enter your email address to follow this blog and receive notifications of new posts by email.

Top Posts & Pages

  • Humor: MAHAspital
  • GI Bleeding -Forrest Classification
  • Safe Baby Formula Choices Based on Consumer Reports Testing
  • 2026 Review: Eosinophilic Gastrointestinal Diseases (EGIDs)
  • Clostridioides difficile Treatment in 2026
  • Reimbursement Reduction for Gastroenterology Practices
  • Review: Infectious Esophagitis
  • Mike Farrell and The Role of The Consultant
  • Functional Dyspepsia in Clinical Practice
  • How to Score the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) Properly

Log-In

  • Create account
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.com

Recent Posts

  • Humor: MAHAspital
  • Reimbursement Reduction for Gastroenterology Practices
  • Baby-Led Weaning and Less Picky Eaters
  • Variance with Guidelines in Hepatic Hemangiomas
  • Noncirrhotic Portal Hypertension
  • Fatigue in Pediatric Inflammatory Bowel Disease
  • 2026 Review: Eosinophilic Gastrointestinal Diseases (EGIDs)
Blog at WordPress.com.
  • Subscribe Subscribed
    • gutsandgrowth
    • Join 943 other subscribers
    • Already have a WordPress.com account? Log in now.
    • gutsandgrowth
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...